Short answer
JACK IN THE BOX INC (JACK) filed an 8-K current report with the SEC on March 4, 2026 reporting Item 3.03 (Material Modification to Rights of Security Holders), Item 5.07 (Submission of Matters to a Vote of Security Holders). Stockholders ratified the poison pill (Rights Agreement) on Feb 27, 2026, extending its expiration to July 1, 2028.
JACK IN THE BOX INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 3.03 · Material Modification to Rights of Security Holders
- Stockholders ratified the poison pill (Rights Agreement) on Feb 27, 2026, extending its expiration to July 1, 2028
- Rights Agreement originally adopted July 1, 2025; stockholder approval locks in anti-takeover protection for ~2 more years
- Pill can be terminated early by the Board, via redemption/exchange, or if JACK completes a qualifying merger
- Extension signals Board actively defending against hostile acquisition attempts: raises barrier for any unsolicited bidder
Item 5.07 · Submission of Matters to a Vote of Security Holders
- David Goebel received only 50.6% support (7.17M for vs 7.01M against): weakest director vote, signaling meaningful shareholder dissatisfaction
- Rights Agreement (poison pill) ratified with 10.82M for vs 4.13M against (~72% support), despite notable opposition: board retaining takeover defense
- Omnibus Incentive Plan share increase approved 9.58M vs 4.35M (~69% support): dilution risk; new shares now available for equity compensation issuance
- Say on Pay passed but with ~29% opposition (4.1M against out of ~15.4M votes cast): elevated dissent on executive pay warrants monitoring
- KPMG reappointed as auditor for FY ending Sept 27, 2026 with strong 13.95M for vs 860K against (~94% support)
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other JACK IN THE BOX INC 8-K filings
Get the next JACK 8-K as it lands
Follow JACK for push alerts, or ask the research agent what this filing means.